Paloma Partners Management CO Repligen Corp Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

A detailed history of Paloma Partners Management CO transactions in Repligen Corp stock. As of the latest transaction made, Paloma Partners Management CO holds 6,932 shares of RGEN stock, worth $987,324. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,932
Previous 1,885 267.75%
Holding current value
$987,324
Previous $237,000 335.02%
% of portfolio
0.03%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $604,580 - $844,615
5,047 Added 267.75%
6,932 $1.03 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $226,200 - $344,860
1,885 New
1,885 $237,000
Q2 2022

Aug 15, 2022
SELL
$140.68 - $188.02 $362,251 - $484,151
-2,575 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $973,748 - $1.56 Million
-6,041 Reduced 70.11%
2,575 $484,000
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $2.13 Million - $2.62 Million
8,616 New
8,616 $2.28 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $846,080 - $1.41 Million
-4,344 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $114,947 - $153,118
693 Added 18.98%
4,344 $867,000
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $126,980 - $159,287
-704 Reduced 16.17%
3,651 $710,000
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $297,936 - $415,618
2,012 Added 85.87%
4,355 $835,000
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $12.6 Million - $16.3 Million
-103,032 Reduced 97.78%
2,343 $346,000
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $9.94 Million - $14.8 Million
105,375 New
105,375 $13 Million
Q2 2019

Aug 14, 2019
SELL
$54.2 - $85.95 $216,691 - $343,628
-3,998 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$49.45 - $62.8 $1.07 Million - $1.36 Million
-21,640 Reduced 84.41%
3,998 $236,000
Q4 2018

Feb 14, 2019
BUY
$48.26 - $68.88 $1.24 Million - $1.77 Million
25,638 New
25,638 $1.35 Million
Q4 2017

Feb 14, 2018
SELL
$32.53 - $38.92 $641,654 - $767,697
-19,725 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$36.98 - $46.06 $729,430 - $908,533
19,725
19,725 $756,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.3M
Call Options Held
350K
Put Options Held
184K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email